Epidermal growth factor-related peptides and their receptors in human malignancies

DS Salomon, R Brandt, F Ciardiello… - Critical reviews in …, 1995 - Elsevier
The development of cancer is due to the accumulation of multiple somatic mutations and in
some cases due to germline mutations, which occur in malignancies such as retinoblastoma …

Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors

LN Klapper, MH Kirschbaum, M Seta… - Advances in cancer …, 1999 - Elsevier
Publisher Summary Carcinoma, cancer of epithelial cells, is a major cause of morbidity and
mortality. Clonal fixation and propagation of oncogenic genetic changes, sporadically …

HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies

DP English, DM Roque, AD Santin - Molecular diagnosis & therapy, 2013 - Springer
HER2 or ErbB2 is a member of the epidermal growth factor family and is overexpressed in
subsets of breast, ovarian, gastric, colorectal, pancreatic, and endometrial cancers. HER2 …

Endometrial carcinoma: pathology and genetics

J Prat, A Gallardo, M Cuatrecasas, L Catasús - Pathology, 2007 - Taylor & Francis
In the Western world, endometrial carcinoma is the most common malignant tumour of the
female genital tract and the fourth most common cancer in women after carcinomas of …

[HTML][HTML] The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy

AA Clancy, JN Spaans, JI Weberpals - Annals of Oncology, 2016 - Elsevier
Background The incidence of vulvar squamous cell carcinoma (VSCC) has been on the rise
since the 1990s. There has been no new treatment for advanced and recurrent disease in …

Squamous cell carcinoma of the vulva: a subclassification of 97 cases by clinicopathologic, immunohistochemical, and molecular features (p16, p53, and EGFR)

F Dong, S Kojiro, DR Borger… - The American journal …, 2015 - journals.lww.com
Squamous cell carcinomas (SCCs) of the vulva develop through human papilloma virus
(HPV)-associated or HPV-independent pathways, but the relationship between …

Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive …

GS Akerman, WH Tolleson, KL Brown, LL Zyzak… - Cancer research, 2001 - AACR
Epidermal growth factor receptor (EGFR) levels are dramatically increased in human
keratinocytes (HKc) immortalized with full-length human papillomavirus type 16 (HPV16) …

Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva

NS Horowitz, AB Olawaiye, DR Borger… - Gynecologic …, 2012 - Elsevier
OBJECTIVE: To evaluate the efficacy and toxicity of erlotinib in the management of
squamous cell carcinoma (SCC) of the vulva. METHODS: Patients with vulvar lesions …

Anatomy and histology of the cervix

A Ferenczy - Pathology of the female genital tract, 1977 - Springer
Although the cervix was recognized as an organ entity as early as 4500 BC during the third
Egyptian Dynasty, it was Soranus, in the first century AD, who gave the first accurate …

Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting

T Olafsen, GJ Tan, C Cheung, PJ Yazaki… - Protein Engineering …, 2004 - academic.oup.com
An engineered antibody fragment (minibody; scFv-CH3γ1 dimer, M r 80 000) specific for
carcinoembryonic antigen (CEA) has previously demonstrated excellent tumor targeting …